Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Janssen Scientific Affairs, LLC
Sponsor:
Collaborator:
Duke Clinical Research Institute
Information provided by (Responsible Party):
Janssen Scientific Affairs, LLC
ClinicalTrials.gov Identifier:
NCT01701817
First received: October 3, 2012
Last updated: October 8, 2014
Last verified: October 2014
  Purpose

The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF II) is a multicenter, prospective outpatient disease registry to evaluate the utilization of target-specific antithrombotic agents, such as FXa (factor Xa) inhibitors and direct thrombin inhibitors, and associated outcomes. Importantly, the ORBIT AF II registry will permit the collection and analysis of post-approval observational data needed for evaluating the outcomes associated with these new agents when used in broader patient populations outside of clinical studies. The ORBIT-AF II registry will focus on patients with newly diagnosed atrial fibrillation (AF) as well as those who have been recently started on a target-specific oral anticoagulant agent. Taken together, the ORBIT-AF I and ORBIT-AF II registries will offer a broad and contemporary view of AF therapy.


Condition Intervention Phase
Atrial Fibrillation
Other: Patients with Atrial Fibrillation
Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (Orbit-AF II)

Resource links provided by NLM:


Further study details as provided by Janssen Scientific Affairs, LLC:

Primary Outcome Measures:
  • Number of major bleeding events [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    Major bleeding will be defined according to International Society of Thrombosis and Hemostasis (ISTH) criteria.


Secondary Outcome Measures:
  • Number of major adverse cardiac events [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    Major cardiac events are defined as stroke or non-central nervous system (non-CNS) systemic embolism, myocardial infarction, and cardiovascular death.


Estimated Enrollment: 15000
Study Start Date: February 2013
Estimated Study Completion Date: February 2018
Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Patients with Atrial Fibrillation (AF)
(1) patients with new onset/first detected Atrial Fibrillation (AF) diagnosed within the preceding 6 months; or (2) patients with AF who had initiation or transition to a FXa (Factor Xa) inhibitor or a direct thrombin inhibitor within the preceding 3 months.
Other: Patients with Atrial Fibrillation
Treatment patterns of AF according to patient demographics, clinical factors, risk stratification, and geographic regions.

Detailed Description:

The registry will be used to evaluate, describe, and document the safety of target-specific anticoagulant agents (and other antithrombotic agents) in patients with Atrial Fibrillation (AF), the clinical outcomes associated with their use, the treatment patterns and clinical course of patients with AF, including those who undergo cardiac procedures of interest (ablation, cardioversion, catheterization and surgery, for examples), and characteristics of patients with new onset/first-detected AF. Additionally, the registry will be used to summarize patterns of switching or discontinuation of antithrombotic agents in the United States. The registry will be a nationwide collaboration of health care providers (eg, cardiologists, internists, primary care physicians, electrophysiologists, quality improvement personnel, office/practice managers, research coordinators, and pharmacists). Target enrollment will be approximately 15,000 patients. It is anticipated that enrollment will complete in 2 years. Consecutive patients who meet the eligibility criteria will be approached and educated about the registry. Patients who express interest will provide informed consent. Patients enrolled in the registry will be followed for up to 2 years. Patient follow-up by their AF care provider will continue as scheduled according to local clinical practice. Data collection will occur at 6-month intervals for approximately 2 years from the time of enrollment of the patient (baseline, 6, 12, 18, and 24 months). Data capture will include demographics, medical history, cardiovascular history, vital signs, echocardiographic and laboratory data, AF status and type (paroxysmal, persistent, long-standing persistent/permanent), pharmacotherapy, contraindications to oral anticoagulant therapy, and provider specialty. Clinical outcomes and safety data capture will include major adverse cardiac events (MACEs).

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Enrolling physicians will include cardiologists, internists, and electrophysiologists from both academic and private practice who preferably have experience in registry participation.

Criteria

Inclusion Criteria: - Adult patients with incident (initial diagnosis) AF (Atrial Fibrillation) with electrocardiographic documentation or patients with prevalent (existing diagnosis) AF who had initiation or transition to a FXa (Factor Xa) inhibitor or a direct thrombin inhibitor within the preceding 3 months - anticipated ability to adhere to local regularly scheduled follow-up visits

-

Exclusion Criteria:

  • Atrial flutter only - Anticipated life expectancy less than 6 months - short lasting AF secondary to a reversible condition (e.g. hyperthyroidism, pulmonary embolism, post-cardiothoracic surgery) - Participation in a randomized trial of anticoagulation for AF at the time of enrollment - Was enrolled in the ORBIT-I Registry
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01701817

Contacts
Contact: Use link at the bottom of the page to see if you qualify for an enrolling site (see list). If you still have questions: JNJ.CT@sylogent.com

  Hide Study Locations
Locations
United States, Alabama
Recruiting
Cullman, Alabama, United States
Recruiting
Fairhope, Alabama, United States
Recruiting
Mobile, Alabama, United States
Recruiting
Tuscaloosa, Alabama, United States
United States, Arizona
Recruiting
Avondale, Arizona, United States
Recruiting
Glendale, Arizona, United States
Recruiting
Goodyear, Arizona, United States
Recruiting
Sun Cit, Arizona, United States
Recruiting
Tucson, Arizona, United States
United States, California
Recruiting
Alhambra, California, United States
Recruiting
Anaheim, California, United States
Recruiting
Beverly Hills, California, United States
Recruiting
Carlsbad, California, United States
Recruiting
Concord, California, United States
Recruiting
E Palo Alto, California, United States
Recruiting
Fresno, California, United States
Recruiting
Huntington Beach, California, United States
Recruiting
Laguna Hills, California, United States
Recruiting
Long Beach, California, United States
Recruiting
Los Alamitos, California, United States
Recruiting
Los Angeles, California, United States
Recruiting
Manhattan Beach, California, United States
Recruiting
Mission Hills, California, United States
Recruiting
Newport Beach, California, United States
Recruiting
Northridge, California, United States
Recruiting
Pasadena, California, United States
Recruiting
Pomona, California, United States
Recruiting
Rancho Mirage, California, United States
Recruiting
San Pedro, California, United States
Recruiting
Santa Rosa, California, United States
Recruiting
Torrance, California, United States
Recruiting
Torrence, California, United States
Recruiting
Ventura, California, United States
United States, Colorado
Recruiting
Aurora, Colorado, United States
Recruiting
Colorado Springs, Colorado, United States
Recruiting
Lakewood, Colorado, United States
United States, Connecticut
Recruiting
Bridgeport, Connecticut, United States
Recruiting
Guilford, Connecticut, United States
United States, Delaware
Recruiting
Laurel, Delaware, United States
Recruiting
Newark, Delaware, United States
United States, Florida
Recruiting
Bay Pines, Florida, United States
Recruiting
Clearwater, Florida, United States
Recruiting
Coral Springs, Florida, United States
Recruiting
Eustis, Florida, United States
Recruiting
Lakeland, Florida, United States
Recruiting
Miami, Florida, United States
Recruiting
Miramar, Florida, United States
Recruiting
Palm Harbor, Florida, United States
Recruiting
Pensacola, Florida, United States
Recruiting
Port Charlotte, Florida, United States
Recruiting
Tampa, Florida, United States
United States, Georgia
Recruiting
Alpharetta, Georgia, United States
Recruiting
Athens, Georgia, United States
Recruiting
Atlanta, Georgia, United States
Recruiting
Cumming, Georgia, United States
Recruiting
Gainesville, Georgia, United States
Recruiting
Macon, Georgia, United States
Recruiting
Marietta, Georgia, United States
United States, Idaho
Recruiting
Idaho Falls, Idaho, United States
Recruiting
Pocatello, Idaho, United States
United States, Illinois
Recruiting
Aurora, Illinois, United States
Recruiting
Melrose Park, Illinois, United States
Recruiting
New Lenox, Illinois, United States
Recruiting
Peoria, Illinois, United States
Recruiting
Rock Island, Illinois, United States
United States, Indiana
Recruiting
Anderson, Indiana, United States
Recruiting
Bloomington, Indiana, United States
Recruiting
Hammond, Indiana, United States
Recruiting
Indianapolis, Indiana, United States
Recruiting
La Porte, Indiana, United States
Recruiting
South Bend, Indiana, United States
United States, Iowa
Recruiting
Davenport, Iowa, United States
Recruiting
Waterloo, Iowa, United States
United States, Kansas
Recruiting
Overland Park, Kansas, United States
United States, Kentucky
Recruiting
Elizabethtown, Kentucky, United States
Recruiting
Louisvile, Kentucky, United States
United States, Louisiana
Recruiting
Alexandria, Louisiana, United States
Recruiting
Natchitoches, Louisiana, United States
Recruiting
New Orleans, Louisiana, United States
United States, Maine
Recruiting
Rockport, Maine, United States
United States, Maryland
Recruiting
Annapolis, Maryland, United States
Recruiting
Baltimore, Maryland, United States
Recruiting
Salisbury, Maryland, United States
United States, Michigan
Recruiting
Alpena, Michigan, United States
Recruiting
Bay City, Michigan, United States
Recruiting
Grand Blanc, Michigan, United States
Recruiting
Lansing, Michigan, United States
Recruiting
Lapeer, Michigan, United States
Recruiting
Mount Clemens, Michigan, United States
Recruiting
Rochester Hills, Michigan, United States
Recruiting
St. Joseph, Michigan, United States
Recruiting
Traverse City, Michigan, United States
Recruiting
Troy, Michigan, United States
United States, Minnesota
Recruiting
Minneapolis, Minnesota, United States
United States, Missouri
Recruiting
Bridgeton, Missouri, United States
United States, Nebraska
Recruiting
Fremont, Nebraska, United States
United States, Nevada
Recruiting
Las Vegas, Nevada, United States
United States, New Hampshire
Recruiting
Nashua, New Hampshire, United States
United States, New Jersey
Recruiting
Bridgewater, New Jersey, United States
Recruiting
Flemington, New Jersey, United States
Recruiting
Manalapan, New Jersey, United States
Recruiting
Moorestown, New Jersey, United States
Recruiting
Mountain Lakes, New Jersey, United States
Recruiting
Somerset, New Jersey, United States
Recruiting
Toms River, New Jersey, United States
United States, New York
Recruiting
Albany, New York, United States
Recruiting
Flushing, New York, United States
Recruiting
Huntington, New York, United States
Recruiting
Jackson Heights, New York, United States
Recruiting
Jamaica, New York, United States
Recruiting
Jamestown, New York, United States
Recruiting
Mineola, New York, United States
Recruiting
North Massapequa, New York, United States
Recruiting
Utica, New York, United States
United States, North Carolina
Recruiting
Chapel, North Carolina, United States
Recruiting
Durham, North Carolina, United States
Recruiting
Elizabeth City, North Carolina, United States
Recruiting
Greensboro, North Carolina, United States
Recruiting
Pinehurst, North Carolina, United States
Recruiting
Raleigh, North Carolina, United States
Recruiting
Sanford, North Carolina, United States
Recruiting
Spartanburg, North Carolina, United States
United States, Ohio
Recruiting
Canton, Ohio, United States
Recruiting
Cleveland, Ohio, United States
Recruiting
Mansfield, Ohio, United States
Recruiting
Miamisburg, Ohio, United States
Recruiting
Toledo, Ohio, United States
Recruiting
Worthington, Ohio, United States
Recruiting
Youngstown, Ohio, United States
United States, Oregon
Recruiting
Medford, Oregon, United States
United States, Pennsylvania
Recruiting
Abington, Pennsylvania, United States
Recruiting
Chambersburg, Pennsylvania, United States
Recruiting
Doylestown, Pennsylvania, United States
Recruiting
Ephrata, Pennsylvania, United States
Recruiting
Langhorne, Pennsylvania, United States
Recruiting
Lansdale, Pennsylvania, United States
Recruiting
Phildelphia, Pennsylvania, United States
Recruiting
Sayre, Pennsylvania, United States
Recruiting
West Reading, Pennsylvania, United States
Recruiting
Wynnewood, Pennsylvania, United States
Recruiting
Yardley, Pennsylvania, United States
United States, Rhode Island
Recruiting
Providence, Rhode Island, United States
United States, Tennessee
Recruiting
Bristol, Tennessee, United States
Recruiting
Kingsport, Tennessee, United States
Recruiting
Nashville, Tennessee, United States
Recruiting
Oak Ridge, Tennessee, United States
United States, Texas
Recruiting
Austin, Texas, United States
Recruiting
Beaumont, Texas, United States
Recruiting
Corpus Christi, Texas, United States
Recruiting
Fort Sam Houston, Texas, United States
Recruiting
Fort Worth, Texas, United States
Recruiting
Houston, Texas, United States
Recruiting
Katy, Texas, United States
Recruiting
Odessa, Texas, United States
Recruiting
Plano, Texas, United States
Recruiting
Round Rock, Texas, United States
Recruiting
Tomball, Texas, United States
Recruiting
Tyler, Texas, United States
United States, Virginia
Recruiting
Lynchburg, Virginia, United States
Recruiting
Mechanicsville, Virginia, United States
Recruiting
Midlothian, Virginia, United States
Recruiting
Newport News, Virginia, United States
Recruiting
Virginia Beach, Virginia, United States
United States, Washington
Recruiting
Tacoma, Washington, United States
Recruiting
Vancouver, Washington, United States
Recruiting
Walla Walla, Washington, United States
United States, West Virginia
Recruiting
Charleston, West Virginia, United States
United States, Wisconsin
Recruiting
La Crosse, Wisconsin, United States
Recruiting
Milwaukee, Wisconsin, United States
Recruiting
Waukesha, Wisconsin, United States
Recruiting
Wausau, Wisconsin, United States
Puerto Rico
Recruiting
Rio Grande, Puerto Rico
Sponsors and Collaborators
Janssen Scientific Affairs, LLC
Duke Clinical Research Institute
Investigators
Study Director: Janssen Scientific Affairs, LLC Clinical Trial Janssen Scientific Affairs, LLC
  More Information

Additional Information:
No publications provided by Janssen Scientific Affairs, LLC

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Janssen Scientific Affairs, LLC
ClinicalTrials.gov Identifier: NCT01701817     History of Changes
Other Study ID Numbers: CR100871, RIVAROXAFL4002
Study First Received: October 3, 2012
Last Updated: October 8, 2014
Health Authority: United States: Institutional Review Board
United States: Food and Drug Administration

Keywords provided by Janssen Scientific Affairs, LLC:
Atrial Fibrillation
Irregular heart beat

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Cardiovascular Diseases
Heart Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on October 20, 2014